腹腔疾病药物全球市场规模调查和预测，按药物（一线、二线）、区域分析，2022-2029 年

乳糜泻、口炎性腹泻和麸质敏感性肠病是影响小肠的消化系统疾病。

摄入麸质会触发小肠的免疫反应。 腹腔疾病有多种症状，包括腹泻、腹胀、风、疲劳、低血细胞计数（贫血）和骨质疏鬆症。 乳糜泻患病率的增加，增加对乳糜泻意识计划的投资是推动市场增长的关键因素。

乳糜泻患病率的增加促进了全球乳糜泻治疗市场的扩大。 例如，Beyond Celiac Organization 估计，美国每 133 人中就有 1 人（约占人口的 1%）患有乳糜泻。 根据芝加哥大学医学院乳糜泻中心的估计，乳糜泻影响了美国至少 300 万美国人。 此外，预计在预测期内，新兴地区对医疗保健行业投资的增加以及乳糜泻药物研发活动的增加将为市场提供良好的增长前景。 然而，严格的药品审批监管框架阻碍了整个 2022-2029 年预测期内的市场增长。

乳糜泻药物全球市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于品牌产品的主导地位和该地区腹腔疾病发病率的增加，北美在收入方面占据了市场主导地位。 另一方面，由于老年人口和目标人群的增加以及医疗保健行业的增长等因素，预计亚太地区在预测期内将以最高的复合年增长率增长。

市场近期发展

• 2019 年 8 月，美国食品药品监督管理局 (FDA) 批准了 ActoBio Therapeutics 的口服 ActoBiotics AG017 胶囊的新药研究 (IND)。 这种新药是治疗乳糜泻的口服生物候选药物。

全球市场报告范围

• 历史数据：2019-2020-2021
• 估算基准年：2021 年
• 预测期：2022-2029
• 报告范围：收入预测、公司排名、竞争格局、增长因素、趋势
• 按地区划分：北美、欧洲、亚太地区、拉丁美洲、世界其他地区
• 定制范围：免费报告定制（最多 8 个工作小时）。 按国家、地区和部门划分的范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年各细分市场的全球市场估计和预测
  • 2019-2029 年各地区乳糜泻药物市场
  • 乳糜泻药物市场，按药物分类，2019-2029 年
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章乳糜泻药物全球市场的定义和范围

• 调查目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 本次调查涵盖的年份
• 货币兑换率

第三章乳糜泻药物的全球市场动态

• 腹腔药物市场影响分析 (2019-2029)
  • 市场驱动因素
    • 乳糜泻的发病率增加
    • 扩大对乳糜泻宣传计划的投资
  • 市场挑战
    • 严格的药品审批监管框架
  • 市场机会
    • 增加对新兴国家/地区医疗保健行业的投资
    • 启动与乳糜泻治疗药物相关的研发活动

第四章乳糜泻药物全球市场行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 最佳投资机会
• 关键成功策略
• 业内人士的前景
• 分析师的建议和结论

第 5 章风险评估 COVID-19 影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章乳糜泻药物的全球市场：按药物分类

• 市场概况
• 乳糜泻药物的全球市场：药物和性能的潜力分析
• 2019-2029 年乳糜泻药物全球市场估计和预测
• 乳糜泻药物市场细分分析
  • 一线治疗
  • 二线治疗

第 7 章全球乳糜泻药物市场：区域分析

• 乳糜泻药物市场，按地区划分的市场概况
• 北美
  • 美国
    • 2019-2029 年各药物的估计和预测
  • 加拿大
• 欧洲乳糜泻药物市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲
• 亚太地区乳糜泻药物市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲乳糜泻药物市场概况
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地区
• 世界其他地方

第 8 章衝突信息

• 顶级市场策略
• 公司简介
  • F. Hoffmann La Roche
    • 关键信息
    • 概览
    • 财务（仅当数据可用时）
    • 产品概述
    • 近期趋势
  • Merck & Co., Inc.
  • Johnson & Johnson
  • BiolineRx Ltd.
  • Pfizer Inc.
  • Innovate Biopharmaceuticals
  • ImmusanT, Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Immunomedics, Inc.

第九章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查的特点
• 调查先决条件

Global Celiac Disease Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Celiac Disease or celiac sprue or gluten-sensitive enteropathy is a digestive problem that affects small intestine. Consumption of gluten triggers an immune response in the small intestine. There are different symptoms of Celiac disease including diarrhoea, bloating, wind, fatigue, low blood count (anaemia) and osteoporosis among others. The increasing incidence of Celiac Disease and growing investments in celiac disease awareness programs are key factors driving the market growth.

The increasing prevalence of Celiac Disease is contributing towards the expansion of Global Celiac Disease Treatment Market. For instance - as per Beyond Celiac Organization - in the United States an estimated 1 in 133 Americans, or about 1% of the population, has celiac disease. Moreover, as per the University of Chicago Medicine's Celiac disease Center estimates - in USA Celiac disease affects at least 3 million Americans. Also, increasing investment in healthcare sector in developing region and rising R&D activities related to celiac disease drugs would create lucrative growth prospectus for the market over the forecast period. However, stringent regulatory framework for drug approval stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Celiac Disease Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and increasing incidences of celiac diseases in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and the growing healthcare sector in the region.

Major market players included in this report are:

• F. Hoffmann-La Roche
• Merck & Co., Inc.
• Johnson & Johnson
• BiolineRx Ltd.
• Pfizer Inc.
• Innovate Biopharmaceuticals
• ImmusanT, Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• Immunomedics, Inc.

Recent Developments in the Market:

• In August 2019, the US Food and Drug Administration (FDA) approved an investigational new drug (IND) for oral ActoBiotics AG017 capsules from ActoBio Therapeutics. This new drug is an oral biologic drug candidate for the reversal of celiac disease.

Global Celiac Disease Drugs Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Drugs, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drugs

• First Line of Treatment
• Second Line of Treatment

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Celiac Disease Drugs Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Celiac Disease Drugs Market, by Drugs, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Celiac Disease Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Celiac Disease Drugs Market Dynamics

• 3.1. Celiac Disease Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of Celiac Disease
    • 3.1.1.2. Growing investments in celiac disease awareness programs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Stringent regulatory framework for drug approval
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing investment in healthcare sector in developing region
    • 3.1.3.2. Rising R&D activities related to celiac disease drugs

Chapter 4. Global Celiac Disease Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Celiac Disease Drugs Market, by Drugs

• 6.1. Market Snapshot
• 6.2. Global Celiac Disease Drugs Market by Drugs, Performance - Potential Analysis
• 6.3. Global Celiac Disease Drugs Market Estimates & Forecasts by Drugs 2019-2029 (USD Billion)
• 6.4. Celiac Disease Drugs Market, Sub Segment Analysis
  • 6.4.1. First Line of Treatment
  • 6.4.2. Second Line of Treatment

Chapter 7. Global Celiac Disease Drugs Market, Regional Analysis

• 7.1. Celiac Disease Drugs Market, Regional Market Snapshot
• 7.2. North America Celiac Disease Drugs Market
  • 7.2.1. U.S. Celiac Disease Drugs Market
    • 7.2.1.1. Drugs breakdown estimates & forecasts, 2019-2029
  • 7.2.2. Canada Celiac Disease Drugs Market
• 7.3. Europe Celiac Disease Drugs Market Snapshot
  • 7.3.1. U.K. Celiac Disease Drugs Market
  • 7.3.2. Germany Celiac Disease Drugs Market
  • 7.3.3. France Celiac Disease Drugs Market
  • 7.3.4. Spain Celiac Disease Drugs Market
  • 7.3.5. Italy Celiac Disease Drugs Market
  • 7.3.6. Rest of Europe Celiac Disease Drugs Market
• 7.4. Asia-Pacific Celiac Disease Drugs Market Snapshot
  • 7.4.1. China Celiac Disease Drugs Market
  • 7.4.2. India Celiac Disease Drugs Market
  • 7.4.3. Japan Celiac Disease Drugs Market
  • 7.4.4. Australia Celiac Disease Drugs Market
  • 7.4.5. South Korea Celiac Disease Drugs Market
  • 7.4.6. Rest of Asia Pacific Celiac Disease Drugs Market
• 7.5. Latin America Celiac Disease Drugs Market Snapshot
  • 7.5.1. Brazil Celiac Disease Drugs Market
  • 7.5.2. Mexico Celiac Disease Drugs Market
  • 7.5.3. Rest of Latin America Celiac Disease Drugs Market
• 7.6. Rest of The World Celiac Disease Drugs Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. F. Hoffmann La Roche
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Merck & Co., Inc.
  • 8.2.3. Johnson & Johnson
  • 8.2.4. BiolineRx Ltd.
  • 8.2.5. Pfizer Inc.
  • 8.2.6. Innovate Biopharmaceuticals
  • 8.2.7. ImmusanT, Inc.
  • 8.2.8. Novartis AG
  • 8.2.9. Bristol-Myers Squibb Company
  • 8.2.10. Immunomedics, Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Celiac Disease Drugs Market, report scope
• TABLE 2. Global Celiac Disease Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Celiac Disease Drugs Market estimates & forecasts by Drugs 2019-2029 (USD Billion)
• TABLE 4. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 5. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. U.S. Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 16. U.S. Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. Canada Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. Canada Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. UK Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. UK Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. Germany Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. Germany Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. France Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. France Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. Italy Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. Italy Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Spain Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Spain Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. RoE Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. RoE Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. China Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. China Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. India Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. India Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. Japan Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. Japan Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. South Korea Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. South Korea Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. Australia Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. Australia Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. RoAPAC Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. Brazil Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. Brazil Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Mexico Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Mexico Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. RoLA Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. RoLA Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. Row Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. Row Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. List of secondary sources, used in the study of global Celiac Disease Drugs Market
• TABLE 69. List of primary sources, used in the study of global Celiac Disease Drugs Market
• TABLE 70. Years considered for the study
• TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Celiac Disease Drugs Market, research methodology
• FIG 2. Global Celiac Disease Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Celiac Disease Drugs Market, key trends 2021
• FIG 5. Global Celiac Disease Drugs Market, growth prospects 2022-2029
• FIG 6. Global Celiac Disease Drugs Market, porters 5 force model
• FIG 7. Global Celiac Disease Drugs Market, pest analysis
• FIG 8. Global Celiac Disease Drugs Market, value chain analysis
• FIG 9. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Celiac Disease Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Celiac Disease Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable